We are live on ! Find out more
TI

tru Independence Portfolio holdings

AUM $202M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
-20.27%
1 Year Est. Return
+15.81%
3 Year Est. Return
+42.5%
5 Year Est. Return
+46.34%
10 Year Est. Return
AUM
$613K
AUM Growth
-$694M
Cap. Flow
-$229M
Cap. Flow %
-37,377.98%
Top 10 Hldgs %
43.1%
Holding
965
New
6
Increased
47
Reduced
75
Closed
214

Sector Composition

Rank Sector Weight
1 Technology 10.3%
2 Healthcare 9.04%
3 Financials 7.22%
4 Consumer Staples 6.76%
5 Consumer Discretionary 4.83%

Similar funds

tru Independence's Q1 2020 Portfolio in Review

As of Q1 2020, tru Independence held 965 positions worth $613K, down 100% from $695M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

tru Independence withdrew a net $229M in Q1 2020, closing 214 positions and reducing 75 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $49.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

Against the trend, tru Independence opened a new position in Norbord Inc. worth $3.02K.

  • tru Independence's largest Q1 2020 buy was Norbord Inc.: 254,795 shares worth $3.02K.
  • tru Independence added most to State Street SPDR S&P Biotech ETF in Q1 2020, an estimated $23.5M increase.
  • tru Independence's biggest Q1 2020 reduction was DTE Energy, cutting an estimated $17M.
  • tru Independence fully exited Bristol-Myers Squibb in Q1 2020, selling an estimated $49.3M.
  • tru Independence's ten largest holdings make up 43% of its $613K portfolio in Q1 2020.
  • tru Independence opened 6 new positions and closed 214 in Q1 2020.
  • tru Independence's portfolio value fell 100% quarter-over-quarter to $613K.

Based on tru Independence's 13F filing for Q1 2020, filed 19 May 2020.